Zhejiang Wecome Pharmaceutical Company Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 331.830 million compared to CNY 306.536 million a year ago. Operating income was CNY 73.775 million compared to CNY 69.541 million a year ago. Net income was CNY 63.771 million compared to CNY 58.044 million a year ago. Basic earnings per share from continuing operations was CNY 0.79 compared to CNY 0.96 a year ago.